DRGEM Corporation (KOSDAQ:263690)
5,450.00
+120.00 (2.25%)
At close: Jan 23, 2026
DRGEM Market Cap
DRGEM has a market cap or net worth of 59.38 billion as of January 23, 2026. Its market cap has decreased by -5.12% in one year.
Market Cap
59.38B
Enterprise Value
57.70B
Revenue
98.34B
Ranking
n/a
PE Ratio
7.37
Stock Price
5,450.00
Market Cap Chart
Since November 22, 2018, DRGEM's market cap has decreased from 76.56B to 59.38B, a decrease of -22.44%. That is a compound annual growth rate of -3.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 59.38B | 2.06% |
| Dec 30, 2025 | 58.18B | -6.54% |
| Dec 30, 2024 | 62.26B | -45.72% |
| Dec 28, 2023 | 114.68B | -1.79% |
| Dec 29, 2022 | 116.78B | -13.05% |
| Dec 30, 2021 | 134.30B | -29.41% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 22, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Noul Co.,Ltd. | 97.09B |
| QuantaMatrix | 91.41B |
| Remed | 86.39B |
| Hironic | 74.74B |
| JPI Healthcare | 73.01B |
| Neofect | 53.33B |
| Genoray | 51.20B |
| UXN Co., Ltd. | 40.50B |